Liron Carmel - Medigus Chief Officer
| MDGSDelisted Stock | USD 1.73 0.01 0.58% |
Executive
Mr. Liron Carmel is Chief Executive Officer of the company. Mr. Carmel serves as Chief Executive Officer and director of CannaPowder, a biopharma company dedicated to developing and applying innovative technology in the cannabinoid field. Mr. Carmel also serves as a director of Chiron Refineries Ltd., a company engaged in consulting and initiation of transactions in the refineries field. In addition he serves as chairman of the Israel Tennis Table Association. He also served as vice president business development at Yaad Givatayim development, a municipal corporation dedicated to initiate, develop and establish projects of public importance. Prior to Yaad Givatayim, Mr. Carmel served as an investment manager and as a research and strategy analyst at Excellence Nessuah, one of the leading companies in the field of provident and advanced studies funds in Israel. since 2019.
| Age | 39 |
| Tenure | 5 years |
| Phone | 972 73 370 4691 |
| Web | https://www.medigus.com |
Medigus Management Efficiency
The company has return on total asset (ROA) of (0.0663) % which means that it has lost $0.0663 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3072) %, meaning that it created substantial loss on money invested by shareholders. Medigus' management efficiency ratios could be used to measure how well Medigus manages its routine affairs as well as how well it operates its assets and liabilities.Medigus Ltd ADR currently holds 10.13 M in liabilities with Debt to Equity (D/E) ratio of 0.27, which may suggest the company is not taking enough advantage from borrowing. Medigus Ltd ADR has a current ratio of 1.35, which is within standard range for the sector. Note, when we think about Medigus' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| John Shumaker | Paragon 28 | N/A | |
| Corey Hancock | Nortech Systems Incorporated | N/A | |
| Matt Brinckman | Paragon 28 | N/A | |
| Shmuel Gov | STRATA Skin Sciences | 64 | |
| Monica Hamling | Nortech Systems Incorporated | N/A | |
| Mark Hooley | Nortech Systems Incorporated | N/A | |
| Indranil Dey | Bluejay Diagnostics | 61 | |
| Gilead Moiseyev | Brainsway | N/A | |
| Jay Sturm | STRATA Skin Sciences | 68 | |
| FACC MD | Nuwellis | N/A | |
| Jeff Sears | Paragon 28 | N/A | |
| Hans Kestler | Paragon 28 | N/A | |
| John Kowalczyk | Nuwellis | N/A | |
| Hillegonda Groen | Brainsway | 55 | |
| Vojislav MD | Delcath Systems | 57 | |
| Vitaliy Epshteyn | Nuwellis | 46 | |
| Robert Scott | Nuwellis | 43 | |
| Kevin Williamson | Tenon Medical | 39 | |
| Les DeLuca | Bluejay Diagnostics | N/A | |
| Martha Rook | Delcath Systems | 54 | |
| Teryl Sides | SurModics | 54 | |
Management Performance
| Return On Equity | -0.31 | |||
| Return On Asset | -0.0663 |
Medigus Ltd ADR Leadership Team
Elected by the shareholders, the Medigus' board of directors comprises two types of representatives: Medigus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medigus. The board's role is to monitor Medigus' management team and ensure that shareholders' interests are well served. Medigus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medigus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ilan Oren, Executive Officer | ||
| Yaron Silberman, Chief Ltd | ||
| Liron Carmel, Chief Officer | ||
| Tali Dinar, Chief Officer |
Medigus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medigus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.31 | |||
| Return On Asset | -0.0663 | |||
| Profit Margin | (0.13) % | |||
| Operating Margin | (0.09) % | |||
| Current Valuation | 65.3 M | |||
| Shares Outstanding | 1.89 M | |||
| Shares Owned By Institutions | 0.29 % | |||
| Number Of Shares Shorted | 4.18 K | |||
| Price To Earning | 33.86 X | |||
| Price To Book | 0.15 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Medigus Stock
If you are still planning to invest in Medigus Ltd ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigus' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |